brentuximab vedotin
seagen,takeda
['brentuximab vedotin', 'lymphoma', 'hodgkin']
patients with advanced classical #hodgkinlymphoma treated with first line brentuximab vedotin plus chemotherapy showed substantial improvements in overall survival, new research shows. #eha2022
Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.